Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Case report

A successful antimicrobial regime for Chromobacterium violaceum induced bacteremia

Authors: James I Campbell, Nguyen Phu Huong Lan, Phan Tu Qui, Le Thi Dung, Jeremy J Farrar, Stephen Baker

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

Chromobacterium violaceum is a proteobacterium found in soil and water in tropical regions. The organism rarely causes infection in humans, yet can cause a severe systemic infection by entering the bloodstream via an open wound.

Case presentation

We recently identified a case of severe bacteremia caused by Chromobacterium violaceum at the Hospital for Tropical Diseases (HTD) in Ho Chi Minh City, Vietnam. Here, we describe how rapid microbiological identification and a combination of antimicrobials was used to successfully treat this life threatening infection in a four-year-old child.

Conclusions

This case shows the need for rapid diagnosis when there is the suspicion of a puncture wound contaminated with water and soil in tropical regions. We suggest that the aggressive antimicrobial combination used here is considered when this infection is suspected.
Literature
1.
go back to reference Lima-Bittencourt CI, Astolfi-Filho S, Chartone-Souza E, Santos FR, Nascimento AM: Analysis of Chromobacterium sp. natural isolates from different Brazilian ecosystems. BMC Microbiol. 2007, 7: 58-10.1186/1471-2180-7-58.CrossRefPubMedPubMedCentral Lima-Bittencourt CI, Astolfi-Filho S, Chartone-Souza E, Santos FR, Nascimento AM: Analysis of Chromobacterium sp. natural isolates from different Brazilian ecosystems. BMC Microbiol. 2007, 7: 58-10.1186/1471-2180-7-58.CrossRefPubMedPubMedCentral
2.
go back to reference Teoh AY, Hui M, Ngo KY, Wong J, Lee KF, Lai PB: Fatal septicaemia from Chromobacterium violaceum: case reports and review of the literature. Hong Kong Med J. 2006, 12 (3): 228-231.PubMed Teoh AY, Hui M, Ngo KY, Wong J, Lee KF, Lai PB: Fatal septicaemia from Chromobacterium violaceum: case reports and review of the literature. Hong Kong Med J. 2006, 12 (3): 228-231.PubMed
3.
go back to reference Baker S, Campbell JI, Stabler R, Nguyen HV, To DS, Nguyen DV, Farrar J: Fatal wound infection caused by Chromobacterium violaceum in Ho Chi Minh City, Vietnam. J Clin Microbiol. 2008, 46 (11): 3853-3855. 10.1128/JCM.01068-08.CrossRefPubMedPubMedCentral Baker S, Campbell JI, Stabler R, Nguyen HV, To DS, Nguyen DV, Farrar J: Fatal wound infection caused by Chromobacterium violaceum in Ho Chi Minh City, Vietnam. J Clin Microbiol. 2008, 46 (11): 3853-3855. 10.1128/JCM.01068-08.CrossRefPubMedPubMedCentral
4.
go back to reference August PR, Grossman TH, Minor C, Draper MP, MacNeil IA, Pemberton JM, Call KM, Holt D, Osbourne MS: Sequence analysis and functional characterization of the violacein biosynthetic pathway from Chromobacterium violaceum. J Mol Microbiol Biotechnol. 2000, 2 (4): 513-519.PubMed August PR, Grossman TH, Minor C, Draper MP, MacNeil IA, Pemberton JM, Call KM, Holt D, Osbourne MS: Sequence analysis and functional characterization of the violacein biosynthetic pathway from Chromobacterium violaceum. J Mol Microbiol Biotechnol. 2000, 2 (4): 513-519.PubMed
5.
go back to reference CLSI: Performance Standards For Antimicrobial Susceptibility Testing M100-S1 Volume 31 No.1. 2001, Clinical and Laboratory Standards Institute: Twenty-first Informational Supplement CLSI: Performance Standards For Antimicrobial Susceptibility Testing M100-S1 Volume 31 No.1. 2001, Clinical and Laboratory Standards Institute: Twenty-first Informational Supplement
6.
go back to reference Fantinatti-Garboggini F, Almeida R, Portillo Vdo A, Barbosa TA, Trevilato PB, Neto CE, Coelho RD, Silva DW, Bartoleti LA, Hanna ES, et al: Drug resistance in Chromobacterium violaceum. Genet Mol Res. 2004, 3 (1): 134-147.PubMed Fantinatti-Garboggini F, Almeida R, Portillo Vdo A, Barbosa TA, Trevilato PB, Neto CE, Coelho RD, Silva DW, Bartoleti LA, Hanna ES, et al: Drug resistance in Chromobacterium violaceum. Genet Mol Res. 2004, 3 (1): 134-147.PubMed
7.
go back to reference Ti TY, Tan WC, Chong AP, Lee EH: Nonfatal and fatal infections caused by Chromobacterium violaceum. Clin Infect Dis. 1993, 17: 505-507. 10.1093/clinids/17.3.505.CrossRefPubMed Ti TY, Tan WC, Chong AP, Lee EH: Nonfatal and fatal infections caused by Chromobacterium violaceum. Clin Infect Dis. 1993, 17: 505-507. 10.1093/clinids/17.3.505.CrossRefPubMed
8.
go back to reference Sneath PHA, Whelan JPF, Singh RB, Edward D: Fatal infection by Chromobacterium violaceum. Lancet. 1953, ii: 276-277.CrossRef Sneath PHA, Whelan JPF, Singh RB, Edward D: Fatal infection by Chromobacterium violaceum. Lancet. 1953, ii: 276-277.CrossRef
9.
go back to reference de Siqueiera IC, Dias J, Ruf H, Ramos EAG, Rolim A, Jabur L, Vasconcelos L, Silvany C, M 163 aciel EAP: Chromombacterium violaceaum in Siblings in Brazil. Emerging Infectious Diseases-http://www.cdc.gov/eid.vol1, No.9 September 2005, de Siqueiera IC, Dias J, Ruf H, Ramos EAG, Rolim A, Jabur L, Vasconcelos L, Silvany C, M 163 aciel EAP: Chromombacterium violaceaum in Siblings in Brazil. Emerging Infectious Diseases-http://​www.​cdc.​gov/​eid.​vol1, No.9 September 2005,
10.
go back to reference Slesak G, Douangdala P, Inthalad S, Silisouk J, Vongsouvath M, Sengduangphachanh A, Moore CE, Mayxay M, Matsuoka H, Newton PN: Fatal Chromobacterium violaceum septicaemia in northern Laos, a modified oxidase test and post-mortem forensic family G6PD analysis. Ann Clin Microbiol Antimicrob. 2009, 8: 24-10.1186/1476-0711-8-24.CrossRefPubMedPubMedCentral Slesak G, Douangdala P, Inthalad S, Silisouk J, Vongsouvath M, Sengduangphachanh A, Moore CE, Mayxay M, Matsuoka H, Newton PN: Fatal Chromobacterium violaceum septicaemia in northern Laos, a modified oxidase test and post-mortem forensic family G6PD analysis. Ann Clin Microbiol Antimicrob. 2009, 8: 24-10.1186/1476-0711-8-24.CrossRefPubMedPubMedCentral
Metadata
Title
A successful antimicrobial regime for Chromobacterium violaceum induced bacteremia
Authors
James I Campbell
Nguyen Phu Huong Lan
Phan Tu Qui
Le Thi Dung
Jeremy J Farrar
Stephen Baker
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-4

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine